Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print March 20, 2003, 10.1148/radiol.2272011833

(Radiology 2003;227:361.)

A more recent version of this article appeared on May 1, 2003
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow All Versions of this Article:
2272011833v1
227/2/361    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albrecht, T.
Right arrow Articles by LeFevre, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albrecht, T.
Right arrow Articles by LeFevre, F.
© RSNA, 2003

Ultrasonography

Improved Detection of Hepatic Metastases with Pulse-Inversion US during the Liver-specific Phase of SHU 508A: Multicenter Study1

Thomas Albrecht, MD, FRCR, Martin J. K. Blomley, MD, FRCR, Peter N. Burns, PhD, Stephanie Wilson, MD, Christopher J. Harvey, MBBS, FRCR, Edward Leen, MD, FRCR, Michel Claudon, MD, Fabrizio Calliada, MD, Jean-Michel Correas, MD, Michel LaFortune, MD, Rodolfo Campani, MD, Christian W. Hoffmann, MD, David O. Cosgrove, MBBS, FRCR and Frederic LeFevre, MD

1 From the Dept of Radiology and Nuclear Medicine, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, D-12200 Berlin, Germany (T.A., C.W.H.); Dept of Imaging, Hammersmith Hosp, Imperial College, London, England (M.J.K.B., C.J.H., D.O.C.); Sunnybrook Imaging Research, Univ of Toronto, Ontario, Canada (P.N.B.); Dept of Ultrasound, Toronto General Hosp-Univ Health Network, Ontario, Canada (S.W.); Dept of Radiology, Royal Infirmary, Glasgow, Scotland (E.L.); Dept of Radiology, CHU Nancy-Brabois, Nancy-Vandoeuvre, France (M.C., F.L.); Ospedale Maggiore di Lodi, Italy (F.C.); Dept of Adult Radiology, Centre Hosp Necker, Paris, France (J.M.C.); Hosp Saint-Luc, Montreal, Quebec, Canada (M.L.); and Dept of Radiology, IRCCS Policlinico S. Matteo, Univ of Pavia, Italy (R.C.). From the 1999 RSNA scientific assembly. Received Nov 15, 2001; revision requested Feb 1, 2002; revision received Jun 28; accepted Aug 27. Supported by a grant from Philips Ultrasound, Bothell, Wash. C.J.H. supported by a grant from the Medical Research Council, United Kingdom. M.J.K.B. supported by a grant from Schering, Berlin, Germany. P.N.B. supported by the National Cancer Institute of Canada. Address correspondence to T.A. (e-mail: thomas.albrecht@medizin.fu-berlin.de).

PURPOSE: To compare conventional B-mode ultrasonography (US) alone with the combination of conventional B-mode US and contrast material–enhanced (SHU 508A) late-phase pulse-inversion US for the detection of hepatic metastases by using dual-phase spiral computed tomography (CT) as the standard of reference.

MATERIALS AND METHODS: One hundred twenty-three patients underwent conventional US, US in the liver-specific phase of SHU 508A, and single-section spiral CT. US and CT images were assessed by blinded readers. Differences in sensitivity, specificity, and the number and smallest size of metastases at conventional and contrast-enhanced US were compared by using CT as the standard of reference. Lesion conspicuity was assessed objectively (quantitatively) and subjectively by one reader before and after contrast material administration.

RESULTS: In 45 of 80 (56%) patients with metastases, more metastases were seen at contrast-enhanced US than at conventional US. In three of these patients, conventional US images appeared normal. The addition of contrast-enhanced US improved sensitivity for the detection of individual metastases from 71% to 87% (P < .001). On a patient basis, sensitivity improved from 94% to 98% (P = .44), and specificity improved from 60% to 88% (P < .01). Contrast enhancement improved the subjective conspicuity of metastases in 66 of 75 (88%) patients and the objective contrast by a mean of 10.8 dB (P < .001). Contrast-enhanced US showed more metastases than did CT in seven patients, and CT showed more than did contrast-enhanced US in one of 22 patients in whom an independent reference (magnetic resonance imaging, intraoperative US, or pathologic findings) was available.

CONCLUSION: Contrast-enhanced US improved sensitivity and specificity in the detection of hepatic metastases.

© RSNA, 2003

Index terms: Liver neoplasms, CT, 761.12115 • Liver neoplasms, metastases, 761.33 • Liver neoplasms, US, 761.1298, 761.12988 • Ultrasound (US), contrast media, 761.12988




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
P S SIDHU
The EFSUMB guidelines for contrast-enhanced ultrasound are comprehensive and informative for good clinical practice: will radiologists take the lead?
Br. J. Radiol., July 1, 2008; 81(967): 524 - 525.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
L. Chami, N. Lassau, D. Malka, M. Ducreux, S. Bidault, A. Roche, and D. Elias
Benefits of Contrast-Enhanced Sonography for the Detection of Liver Lesions: Comparison with Histologic Findings
Am. J. Roentgenol., March 1, 2008; 190(3): 683 - 690.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
B. Lanka, H.-J. Jang, T. K. Kim, P. N. Burns, and S. R. Wilson
Impact of Contrast-Enhanced Ultrasonography in a Tertiary Clinical Practice
J. Ultrasound Med., December 1, 2007; 26(12): 1703 - 1714.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
L. Greenbaum, P. Burns, J. Copel, D. Cosgrove, J. B. Fowlkes, B. Goldberg, R. Mattrey, D. Merton, M. Robbin, and S. Wilson
American Institute of Ultrasound in Medicine Recommendations for Contrast-Enhanced Liver Ultrasound Imaging Clinical Trials
J. Ultrasound Med., June 1, 2007; 26(6): 705 - 716.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. J. Dill-Macky, S. R. Wilson, Y. Sternbach, J. Kachura, and T. Lindsay
Detecting Endoleaks in Aortic Endografts Using Contrast-Enhanced Sonography
Am. J. Roentgenol., March 1, 2007; 188(3): W262 - W268.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
E. Leen, P. Ceccotti, C. Kalogeropoulou, W. J. Angerson, S. J. Moug, and P. G. Horgan
Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography.
Am. J. Roentgenol., June 1, 2006; 186(6): 1551 - 1559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. Nicolau, R. Vilana, V. Catala, L. Bianchi, R. Gilabert, A. Garcia, and C. Bru
Importance of Evaluating All Vascular Phases on Contrast-Enhanced Sonography in the Differentiation of Benign from Malignant Focal Liver Lesions
Am. J. Roentgenol., January 1, 2006; 186(1): 158 - 167.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M. Okada, C. W. Hoffmann, K. J. Wolf, and T. Albrecht
Bolus versus Continuous Infusion of Microbubble Contrast Agent for Liver US: Initial Experience
Radiology, December 1, 2005; 237(3): 1063 - 1067.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
S. Bipat, M. S. van Leeuwen, E. F. I. Comans, M. E. J. Pijl, P. M. M. Bossuyt, A. H. Zwinderman, and J. Stoker
Colorectal Liver Metastases: CT, MR Imaging, and PET for Diagnosis--Meta-analysis
Radiology, October 1, 2005; 237(1): 123 - 131.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H. Ding, W.-P. Wang, B.-J. Huang, R.-X. Wei, N.-A. He, Q. Qi, and C.-L. Li
Imaging of Focal Liver Lesions: Low-Mechanical-Index Real-time Ultrasonography With SonoVue
J. Ultrasound Med., March 1, 2005; 24(3): 285 - 297.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
C Harvey and M Blomley
Imaging investigation of liver haemodynamics in patients at risk for hepatic metastatic disease
Br. J. Radiol., February 1, 2005; 78(926): 103 - 104.
[Full Text] [PDF]


Home page
J Ultrasound MedHome page
A. C. Fleischer, K. J. Niermann, E. F. Donnelly, T. E. Yankeelov, K. M. Canniff, D. E. Hallahan, and M. E. Rothenberg
Sonographic Depiction of Microvessel Perfusion: Principles and Potential
J. Ultrasound Med., November 1, 2004; 23(11): 1499 - 1506.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. H. Bryant, M. J. Blomley, T. Albrecht, P. S. Sidhu, E. L. S. Leen, R. Basilico, J. M. Pilcher, L. H. Bushby, C. W. Hoffmann, C. J. Harvey, et al.
Improved Characterization of Liver Lesions with Liver-Phase Uptake of Liver-specific Microbubbles: Prospective Multicenter Study
Radiology, September 1, 2004; 232(3): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
C F Dietrich, A Ignee, J Trojan, C Fellbaum, and G Schuessler
Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A
Gut, March 1, 2004; 53(3): 401 - 405.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Radiol.Home page
D Cosgrove
Angiogenesis imaging - ultrasound
Br. J. Radiol., December 1, 2003; 76(suppl_1): S43 - S49.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2003 by the Radiological Society of North America.